Company Overview
About Advil
Advil is a global over-the-counter ibuprofen pain relief brand — owned by Haleon plc (LSE: HLN / NYSE: HLN), the consumer healthcare company spun off from GSK on July 18, 2022, with Pfizer completing its full stake exit in early 2025 for $3+ billion — providing consumers with 23+ ibuprofen-based product varieties for pain, headache, cold, and sleep management including Advil Extra Strength, Advil Rapid Release Gels, Advil PM, Advil Dual Action (ibuprofen + acetaminophen), and Children's Advil. Advil entered the US market in 1984 (the first OTC ibuprofen in America, considered the "most famous prescription-to-OTC switch in history") and generates approximately $800 million+ annually as one of Haleon's flagship brands alongside Sensodyne, Panadol, Centrum, and Theraflu. In September 2024, Advil Dual Action became the first OTC pain reliever to earn the American Dental Association (ADA) Seal of Acceptance for temporary management of acute dental pain.
Business Model & Competitive Advantage
Advil's ibuprofen formulation addresses the inflammation-driven pain and fever that makes it the preferred OTC analgesic for musculoskeletal pain, dental pain, menstrual cramps, and fever: ibuprofen's mechanism of action (inhibiting prostaglandin synthesis via COX-1 and COX-2 inhibition) addresses the inflammation component of pain more effectively than acetaminophen for conditions with an inflammatory etiology — making Advil the recommended OTC option for arthritis, muscle injury, headache with tension component, and post-procedure dental pain where inflammation drives the symptom. Advil Dual Action's combination (ibuprofen + acetaminophen) provides complementary pain pathways coverage that clinical studies demonstrate superior efficacy to either agent alone — the mechanism behind the ADA Seal for dental pain management.
Competitive Landscape 2025–2026
In 2025, Advil (Haleon) competes in the OTC analgesic, ibuprofen pain relief, and consumer healthcare market with Tylenol (Kenvue/Kimberly-Clark pending, acetaminophen #1 recommendation), Aleve (Bayer, naproxen sodium), and Motrin IB (Johnson & Johnson/Kenvue) for pharmacist recommendation, retail shelf positioning, and consumer OTC pain relief purchasing. Haleon's standalone strategy (post-GSK spinoff and post-Pfizer exit) focuses Advil investment on brand building, formulation innovation, and international market expansion — without the capital allocation competition from GSK's pharmaceutical pipeline or Pfizer's priorities. The ADA Seal for dental pain (a first in the OTC category) provides a differentiated clinical claim for the dental pain management segment. The 2025 strategy under Haleon CEO Brian McNamara focuses on digital health integration (Advil companion apps for pain tracking), growing Advil PM and Advil Dual Action penetration, and defending shelf position against private label ibuprofen share gains at major retailers.
The Advil Story
Founders
Recent Activity
View all →Company Timeline
Major milestones in Advil's journey
Leadership Team
Meet the leaders behind Advil
Brian McNamara
Brian McNamara serves as CEO of Haleon, the parent company of Advil. He leads the global consumer healthcare company spun off from GSK in 2022, managing brands including Advil, Sensodyne, and Centrum.
Key Differentiators
Emerging Innovator
Advil is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
OliverIQ
OliverIQ is a United States-based smart home technology company — backed with $7.26 million in seed funding in September 2022 from EPIC Ventures, Album VC, Pelion Venture Partners, and Silicon Valley
Hellohive
Hellohive is a New York City-based virtual recruiting platform specializing in diverse early-career talent — backed with $9 million in total funding including a $3.4 million Series A in February 2024
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Noom
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to beha
Hims & Hers
Hims & Hers is a consumer telehealth and pharmacy platform founded in 2017 in San Francisco by Andrew Dudum, built on the mission of making high-quality healthcare affordable and stigma-free for condi
Doximity
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic
Compare Advil with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Advil? Verify your company email to claim this profile and keep its description, products, and FAQs up to date.
Claim Advil Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Advil vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →